<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for VRTX</title>
    <link />
    <description>Headlines for Vertex Pharmaceuticals</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensive Insider Selling</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1457701-1-tech-1-biotech-and-1-business-services-company-with-recent-intensive-insider-selling.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 23 May 2013 14:44:04 GMT</pubDate>
    </item>
    <item>
      <title>$307,000-a-year Vertex Drug: Billions in Sales?</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/vertex_orphan_drug_moving_out_of_the_orphanage.aspx</link>
      <author>YCharts</author>
      <pubDate>Mon, 20 May 2013 16:50:11 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Underperforming Today In The Drugs Industry</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928285/1/5-stocks-underperforming-today-in-the-drugs-industry.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 13:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/17/vertex-calls-for-redemption-of-400-million-in-conv/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 17 May 2013 08:46:32 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Pharmaceuticals (VRTX): Today's Featured Health Care Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11926376/1/vertex-pharmaceuticals-vrtx-todays-featured-health-care-laggard.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 16 May 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks Underperforming Today In The Drugs Industry</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11924650/1/3-stocks-underperforming-today-in-the-drugs-industry.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>2 Scariest Dividend Stocks in Health Care</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/2-scariest-dividend-stocks-in-health-care/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 11:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Racing Toward the Next Hepatitis C Drug Approval</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/racing-toward-the-next-hepatitis-c-drug-approval/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 18:35:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Investment Strategy Lessons From Vertex's Success</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/11/3-investing-lessons-from-this-biotechs-success/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 11 May 2013 09:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/vertex-pharmaceuticals-announces-webcasts-of-its-p/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 09 May 2013 18:23:37 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Debt Conversion Is Not Bad For Shareholders</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1417621-vertex-debt-conversion-is-not-bad-for-shareholders.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 03:25:55 GMT</pubDate>
    </item>
    <item>
      <title>A "Me Too" FDA Breakthrough</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/a-me-too-fda-breakthrough/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 10:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Midcaps Double S&amp;P 500 Return: Get the Right ETF</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/midcaps_double_sandp_500_return_finding_the_right_etf.aspx</link>
      <author>YCharts</author>
      <pubDate>Tue, 07 May 2013 13:00:13 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks Improving Performance Of The Health Care Sector</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11914924/1/3-stocks-improving-performance-of-the-health-care-sector.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 06 May 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1402281-biotech-watchlist-2013-update-exciting-ideas-have-explosive-potential.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 22:18:32 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11913965/1/vertex-pharmaceuticals-vrtx-todays-featured-drugs-laggard.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 03 May 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Don't Worry for a Second About Gilead's Earnings Miss</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/gilead-earnings-may/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 11:46:00 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Pharmaceuticals Beats Analyst Expectations, Yet Insiders Continue To Sell More Shares</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1398351-vertex-pharmaceuticals-beats-analyst-expectations-yet-insiders-continue-to-sell-more-shares.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 07:54:36 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Q1 Results Worse Than 2012, but Better Than Expected</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/vertex-earnings-april/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 21:09:00 GMT</pubDate>
    </item>
    <item>
      <title>Why BioMarin, Catalyst Pharmaceutical Partners And Vertex Are Expected To Outperform</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1389091-why-biomarin-catalyst-pharmaceutical-partners-and-vertex-are-expected-to-outperform.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 11:17:08 GMT</pubDate>
    </item>
  </channel>
</rss>
